• JSC Pharmaceutical Plant Egis (Manufacturer responsible for full production cycle, secondary and primary packaging, batch control and batch release)
• P&G Health Austria GmbH & Co. KG
• P&G Health Austria GmbH & Co. OG (authorization for batch release)
• PJSC "Pivdentehgaz"
• PJSC "Poltava Medical Glass Plant"
• PJSC "Production of Insulins "Indar"
• PJSC "Scientific and Production Center "Borshchahivsky Chemical and Pharmaceutical Plant" (packaging from bulk form of manufacturer Sintom Hispania S.L., Spain)
• PJSC Pharmaceutical Plant EGIS (primary packaging, secondary packaging, quality control, batch release; full production cycle, including batch release)
• PJSC Pharmaceutical Plant EGIS (responsible for full production cycle)
• PJSC Pharmaceutical Plant Egis (Responsible for batch release)
• PJSC Pharmaceutical Plant Egis (batch release)
• PJSC Pharmaceutical Plant Egis (full production cycle, including batch release)
• PJSC Pharmaceutical Plant Egis (manufacturer responsible for full cycle; manufacturer responsible for primary packaging, secondary packaging, batch release)
• PJSC Pharmaceutical Plant Egis (manufacturing and quality control, packaging and batch release)
• PJSC Pharmaceutical Plant Egis (manufacturing, quality control and batch release; primary and secondary packaging, batch release)
• PJSC Pharmaceutical Plant Egis (medicinal product: quality control, secondary packaging)
• PJSC Pharmaceutical Plant Egis (primary, secondary packaging and batch release; full production cycle, batch control and batch release)
• PJSC Pharmaceutical Plant Egis (production unit for 20 mg calcium rosuvastatin tablets placed in capsules; unit responsible for batch control of 20 mg calcium rosuvastatin tablets placed in capsules; unit responsible for batch control of 10 mg ramipril tablets placed in capsules; unit responsible for primary and secondary packaging, batch control, release of finished medicinal product batches; production unit for 10 mg ramipril tablets placed in capsules; unit responsible for batch control of 10 mg ramipril tablets placed in capsules; finished medicinal product production unit; unit responsible for primary and secondary packaging, batch control, batch release of finished medicinal products)
• PJSC Pharmaceutical Plant Egis (quality control, secondary packaging)
• PLIVA Hrvatska d.o.o.
• PLIVA Hrvatska d.o.o. (full-cycle manufacturing; batch control (X-ray diffraction method))
• PPF HASCO-LEK S.A.
• PRO.MED.CS Prague a.s.
• PRO.MED.CS Prague a.s. (all manufacturing stages, quality control and batch release)
• PRO.MED.CS Prague a.s. (full-cycle manufacturing)
• PRO.MED.CS Prague a.s. (manufacturing, primary and secondary packaging, quality control, batch release)
• Panacea Biotek Pharma Ltd.
• Panacea LLC
• Pateon Inc. (manufacturing, primary and secondary packaging, testing at release and stability)
• Pateon Italia S.p.A. (manufacturing of medicinal product, testing at release, stability testing, primary packaging)
• Pateon Italia S.p.A. (manufacturing of products in bulk, primary packaging, quality control)
• Patheon France
• Patheon Italia S.p.A. (manufacturing, primary packaging, quality control testing (sterility))
• Pfizer France (bulk manufacturing and batch control)
• Pfizer Inc. (manufacturer of unpackaged product, primary packaging)
• Pfizer Inc. (stability testing)
• Pfizer Ireland Pharmaceuticals (manufacturing, primary and secondary packaging, quality control)
• Pfizer Italia S.p.A. (manufacturing APIs; primary packaging; quality control at batch release for parameters "Endotoxins" and "Sterility")
• Pfizer Italia S.p.A. (manufacturing GLZ; quality control at batch release for parameter "Sterility") / PPD Development, L.P. (quality control in stability study for parameter "Neutralization analysis of TNF-alpha using NF-kB reporter gene")
• Pfizer Italia S.r.l.
• Pfizer Manufacturing Belgium
• Pfizer Manufacturing Belgium NV
• Pfizer Manufacturing Belgium NV (full-cycle manufacturing, batch release)
• Pfizer Manufacturing Belgium NV (manufacturing medicinal product in pre-filled syringes, quality control of medicinal product in pre-filled syringes, except for the test "Bioanalysis of apoptosis"; assembly and testing of pre-filled pens; labeling, secondary packaging, batch release of finished medicinal product)
• Pfizer Manufacturing Belgium NV (manufacturing, packaging, quality control, batch release)
• Pfizer Manufacturing Belgium NV (manufacturing, primary packaging (cartridge), testing of medicinal solution (endotoxins, sterility, m-cresol) (cartridge); assembly, labeling, testing and secondary packaging of pre-filled pen; batch release)
• Pfizer Manufacturing Belgium NV (manufacturing, quality control and batch release of water for injections in pre-filled syringes, simultaneous packaging and labeling of water for injections and medicinal product; manufacturing medicinal product in bulk and primary packaging; batch release of medicinal product; quality control of medicinal product, excluding the 'Bioassay' test)
• Pfizer Manufacturing Belgium NV (manufacturing, quality control and batch release of water for injections in pre-filled syringes, simultaneous packaging and labeling of water for injections and medicinal product; manufacturing of medicinal product in bulk and primary packaging; batch release of medicinal product; quality control of medicinal product, excluding the 'Bioassay' test)
• Pfizer Manufacturing Belgium NV (secondary packaging, batch release)
• Pfizer Manufacturing Belgium NV (secondary packaging, batch release; manufacturer for diluent - full production cycle and release)